SPARC announces Phase 3 trial results of SDN-037 to treat inflammation and pain of ocular surgery
The primary efficacy measure was the proportion of subjects with an anterior chamber cell (ACC) grade of zero (0) on Day 15 (zero…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.